GlobalData on MSN5mon
Roche’s VENTANA CLDN18 assay gains CE markRoche has gained the Conformité Européenne (CE) mark of approval for its VENTANA CLDN18 (43-14A) RxDx assay to identify ...
(MENAFN- Swissinfo) Thomas Schinecker, CEO of Swiss pharma firm Roche, has dismissed fears that the company's sales targets would be threatened by potential higher US tariffs on Pharmaceutical goods.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback